Carl Zeiss Meditec invests in innovative radiotherapy solution for wet agerelated macular degeneration developed by Oraya Therapeutics, Inc. Oraya Therapy represents an attractive new treatment option for patients

January 7, 2015

Carl Zeiss Meditex AG and Oraya enter a collaboration agreement under which ZEISS will provide funding to Oraya for up to two years to support their growth strategy to accelerate and expand their European market developments.
More »

Tobira Therapeutics' Cenicriviroc Granted Fast Track Designation by the FDA for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients with Liver Fibrosis

January 6, 2015

Tobira Therapeutics enrolls patients in its Phase 2b proof of concept study of CVC in patients with liver fibrosis, after the FDA granted Fast Track designation to CVC for the treatment of NASH in liver fibrosis patients.
More »

Esperion Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference

January 5, 2015

Esperion Therapeutics will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2015 at 8:30 AM PST. A live webcast of the presentation will be available on the investor relations section of their website.
More »